Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Long QT Syndrome

• Study of LQT-1213 on Dofetilide-Induced QTc Prolongation in Healthy Adult Subjects and Patients Diagnosed With Type 2 or 3 Long QT Syndrome
• A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software
• Phase 1 Study of LQT-1213 in Healthy Adults
• Electrophysiological Effects of Potential QT Prolonging Drugs
• Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening
• Mutation-specific Therapy for the Long QT Syndrome
• Novel Form of Acquired Long QT Syndrome
• Effect of Methadone and Hydromorphone on the QT Interval After Anesthesia and Surgery
• The Physiological Effects of Human Ether-a-go-go-Related Gene (hERG)Blockade on Metabolism
• Reducing the Risk of Drug-Induced QT Interval Lengthening in Women
• Exploring Mechanisms and Morphology of QT Interval Prolongation
• CiPA Phase 1 ECG Biomarker Validation Study
• Effect of Grapefruit on QT Interval in Healthy Volunteers and Patients With Congenital Long QT Syndrome
• Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes
• Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function
• Genetics of QT Prolongation With Antiarrhythmics
• Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic Function
• Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Adults
• Study to Evaluate the Effect of Eleclazine on QT, Safety, and Tolerability in Participants With Long QT2 Syndrome
• Ability of Late Sodium or Calcium Current Block to Balance the ECG Effects of Potassium Current Block
• Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3
• Race Difference Moxifloxacin-induced QT Prolongation Between Healthy Chinese and Caucasian Volunteers
• Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University Hospital
• QT-prolongation in Psychiatric Hospitals
• Drug Interactions With Risk of QT-prolongation in a General Hospital
• Influence of Progesterone Administration on Drug-Induced QT Interval Lengthening
• Study of the Effect of GS-6615 in Subjects With LQT-3
• Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine
• Efficacy Study of Sodium Channel Blocker in LQT3 Patients
• Effect of Beta-blocker Therapy on QTc Response in Exercise and Recovery in Normal Subjects
• Study Evaluating the Effects of Multiple Oral Doses of ERB-041 on Cardiac Repolarization in Healthy Subjects